As Chemist Warehouse’s customers flock to Ozempic and other GLP-1 drugs to slim down, the owner of the retail giant, Sigma Healthcare, is looking to bulk up.Just before the ASX opened on Wednesday, Sigma confirmed a Financial Times report that it is in the running to buy The Boots Group, the iconic British pharmacy chain that has put itself up for sale with a $US10 billion ($14 billion) asking price.Subscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber? Fetching latest articles
Decades-long dream powering Chemist Warehouse’s risky tilt at Boots
Chief executive Mario Verrocchi has admired the British pharmacy chain for more than four decades. But any deal to buy the UK group would be laden with risks.
91 words~1 min read
